Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current Advances on Different Kinases Involved in Tau Phosphorylation, and Implications in Alzheimers Disease and Tauopathies

1 Jan 2005

Abstract excerpt

Hyperphosphorylation and accumulation of tau in neurons (and glial cells) is one the main pathologic hallmarks in Alzheimer's disease (AD) and other tauopathies, including Pick's disease (PiD), progressive supranuclear palsy, corticobasal degeneration, argyrophilic grain disease and familial frontotemporal dementia and parkinsonism linked to chromosome 17 due to mutations in the tau gene (FTDP-17-tau)....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Cholinesterase and Neurodegenerative Diseases
Share to Prion Diseases and Protein Misfolding

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15977985
DOI: 10.2174/1567205052772713

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current Advances on Different Kinases Involved in Tau Phosphorylation, and Implications in Alzheimers Disease and TauopathiesPMID 15977985Read ↗

Sites of phosphorylation in tau and factors affecting their regulation.Semantic proximity Read ↗

Increased tau phosphorylation on mitogen-activated protein kinase consensus sites and cognitive decline in transgenic models for Alzheimer's disease and FTDP-17: evidence for distinct molecular processes underlying tau abnormalities.Semantic proximity Read ↗

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.Semantic proximity Read ↗

c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer’s DiseasesSemantic proximity Read ↗

Functional Implications of Glycogen Synthase Kinase‐3‐Mediated Tau PhosphorylationSemantic proximity Read ↗

Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation.Semantic proximity Read ↗

Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processesSemantic proximity Read ↗

Neuronal deficiency of p38α‐MAPK ameliorates symptoms and pathology of APP or Tau‐transgenic Alzheimer’s mouse modelsSemantic proximity Read ↗

A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathiesSemantic proximity Read ↗

Tau protein as a differential biomarker of tauopathies.Semantic proximity Read ↗

Phosphorylation of amyloid beta (Aβ) peptides - a trigger for formation of toxic aggregates in Alzheimer's disease.Semantic proximity Read ↗

Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.